Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clinton Torres is active.

Publication


Featured researches published by Clinton Torres.


Nucleic Acids Research | 2005

AS2TS system for protein structure modeling and analysis

Adam Zemla; C. Ecale Zhou; Tom Slezak; T. Kuczmarski; D. Rama; Clinton Torres; Dorota Sawicka; Daniel Barsky

We present a set of programs and a website designed to facilitate protein structure comparison and protein structure modeling efforts. Our protein structure analysis and comparison services use the LGA (local-global alignment) program to search for regions of local similarity and to evaluate the level of structural similarity between compared protein structures. To facilitate the homology-based protein structure modeling process, our AL2TS service translates given sequence–structure alignment data into the standard Protein Data Bank (PDB) atom records (coordinates). For a given sequence of amino acids, the AS2TS (amino acid sequence to tertiary structure) system calculates (e.g. using PSI-BLAST PDB analysis) a list of the closest proteins from the PDB, and then a set of draft 3D models is automatically created. Web services are available at .


Journal of Veterinary Diagnostic Investigation | 2009

A multiplex real-time reverse transcription polymerase chain reaction assay for detection and differentiation of Bluetongue virus and Epizootic hemorrhagic disease virus serogroups.

William C. Wilson; Benjamin J. Hindson; Emily S. O'Hearn; Sara B. Hall; Christian Tellgren-Roth; Clinton Torres; Pejman Naraghi-Arani; James O. Mecham; Raymond J. Lenhoff

Bluetongue virus (BTV) causes disease in domestic and wild ruminants and results in significant economic loss. The closely related Epizootic hemorrhagic disease virus (EHDV) has been associated with bluetongue-like disease in cattle. Although U.S. EHDV strains have not been experimentally proven to cause disease in cattle, there is serologic evidence of infection in cattle. Therefore, rapid diagnosis and differentiation of BTV and EHDV is required. The genetic sequence information and bioinformatic analysis necessary to design a real-time reverse transcription polymerase chain reaction (RT-PCR) assay for the early detection of indigenous and exotic BTV and EHDV is described. This sequence data foundation focused on 2 conserved target genes: one that is highly expressed in infected mammalian cells, and the other is highly expressed in infected insect cells. The analysis of all BTV and EHDV prototype strains indicated that a complex primer design was necessary for both a virus group-comprehensive and virus group-specific gene amplification diagnostic test. This information has been used as the basis for the development of a rapid multiplex BTV-EHDV real-time RT-PCR that detects all known serotypes of both viruses and distinguishes between BTV and EHDV serogroups. The sensitivity of this rapid, single-tube, real-time RT-PCR assay is sufficient for diagnostic application, without the contamination problems associated with standard gel-based RT-PCR, especially nested RT-PCR tests.


BMC Genomics | 2013

Ultra-deep mutant spectrum profiling: improving sequencing accuracy using overlapping read pairs

Haiyin Chen-Harris; Monica K. Borucki; Clinton Torres; Tom Slezak; Jonathan E. Allen

BackgoundHigh throughput sequencing is beginning to make a transformative impact in the area of viral evolution. Deep sequencing has the potential to reveal the mutant spectrum within a viral sample at high resolution, thus enabling the close examination of viral mutational dynamics both within- and between-hosts. The challenge however, is to accurately model the errors in the sequencing data and differentiate real viral mutations, particularly those that exist at low frequencies, from sequencing errors.ResultsWe demonstrate that overlapping read pairs (ORP) -- generated by combining short fragment sequencing libraries and longer sequencing reads -- significantly reduce sequencing error rates and improve rare variant detection accuracy. Using this sequencing protocol and an error model optimized for variant detection, we are able to capture a large number of genetic mutations present within a viral population at ultra-low frequency levels (<0.05%).ConclusionsOur rare variant detection strategies have important implications beyond viral evolution and can be applied to any basic and clinical research area that requires the identification of rare mutations.


BMC Bioinformatics | 2011

LAVA: An Open-Source Approach To Designing LAMP (Loop-Mediated Isothermal Amplification) DNA Signatures

Clinton Torres; Brian R. Baker; Shea N. Gardner; Marisa W Torres; John M. Dzenitis

BackgroundWe developed an extendable open-source Loop-mediated isothermal AMPlification (LAMP) signature design program called LAVA (LAMP Assay Versatile Analysis). LAVA was created in response to limitations of existing LAMP signature programs.ResultsLAVA identifies combinations of six primer regions for basic LAMP signatures, or combinations of eight primer regions for LAMP signatures with loop primers, which can be used as LAMP signatures. The identified primers are conserved among target organism sequences. Primer combinations are optimized based on lengths, melting temperatures, and spacing among primer sites. We compare LAMP signature candidates for Staphylococcus aureus created both by LAVA and by PrimerExplorer. We also include signatures from a sample run targeting all strains of Mycobacterium tuberculosis.ConclusionsWe have designed and demonstrated new software for identifying signature candidates appropriate for LAMP assays. The software is available for download at http://lava-dna.googlecode.com/.


PLOS ONE | 2013

The Role of Viral Population Diversity in Adaptation of Bovine Coronavirus to New Host Environments

Monica K. Borucki; Jonathan E. Allen; Haiyin Chen-Harris; Adam Zemla; Gilda Vanier; Shalini Mabery; Clinton Torres; Pamela J. Hullinger; Tom Slezak

The high mutation rate of RNA viruses enables a diverse genetic population of viral genotypes to exist within a single infected host. In-host genetic diversity could better position the virus population to respond and adapt to a diverse array of selective pressures such as host-switching events. Multiple new coronaviruses, including SARS, have been identified in human samples just within the last ten years, demonstrating the potential of coronaviruses as emergent human pathogens. Deep sequencing was used to characterize genomic changes in coronavirus quasispecies during simulated host-switching. Three bovine nasal samples infected with bovine coronavirus were used to infect human and bovine macrophage and lung cell lines. The virus reproduced relatively well in macrophages, but the lung cell lines were not infected efficiently enough to allow passage of non lab-adapted samples. Approximately 12 kb of the genome was amplified before and after passage and sequenced at average coverages of nearly 950×(454 sequencing) and 38,000×(Illumina). The consensus sequence of many of the passaged samples had a 12 nucleotide insert in the consensus sequence of the spike gene, and multiple point mutations were associated with the presence of the insert. Deep sequencing revealed that the insert was present but very rare in the unpassaged samples and could quickly shift to dominate the population when placed in a different environment. The insert coded for three arginine residues, occurred in a region associated with fusion entry into host cells, and may allow infection of new cell types via heparin sulfate binding. Analysis of the deep sequencing data indicated that two distinct genotypes circulated at different frequency levels in each sample, and support the hypothesis that the mutations present in passaged strains were “selected” from a pre-existing pool rather than through de novo mutation and subsequent population fixation.


Journal of Clinical Microbiology | 2004

Sequencing Needs for Viral Diagnostics

Shea N. Gardner; Marisa W. Lam; Nisha Mulakken; Clinton Torres; Jason Smith; Tom Slezak

ABSTRACT We built a system to guide decisions regarding the amount of genomic sequencing required to develop diagnostic DNA signatures, which are short sequences that are sufficient to uniquely identify a viral species. We used our existing DNA diagnostic signature prediction pipeline, which selects regions of a target species genome that are conserved among strains of the target (for reliability, to prevent false negatives) and unique relative to other species (for specificity, to avoid false positives). We performed simulations, based on existing sequence data, to assess the number of genome sequences of a target species and of close phylogenetic relatives (near neighbors) that are required to predict diagnostic signature regions that are conserved among strains of the target species and unique relative to other bacterial and viral species. For DNA viruses such as variola (smallpox), three target genomes provide sufficient guidance for selecting species-wide signatures. Three near-neighbor genomes are critical for species specificity. In contrast, most RNA viruses require four target genomes and no near-neighbor genomes, since lack of conservation among strains is more limiting than uniqueness. Severe acute respiratory syndrome and Ebola Zaire are exceptional, as additional target genomes currently do not improve predictions, but near-neighbor sequences are urgently needed. Our results also indicate that double-stranded DNA viruses are more conserved among strains than are RNA viruses, since in most cases there was at least one conserved signature candidate for the DNA viruses and zero conserved signature candidates for the RNA viruses.


Nucleic Acids Research | 2005

Draft versus finished sequence data for DNA and protein diagnostic signature development

Shea N. Gardner; Marisa W. Lam; Jason R. Smith; Clinton Torres; Tom Slezak

Sequencing pathogen genomes is costly, demanding careful allocation of limited sequencing resources. We built a computational Sequencing Analysis Pipeline (SAP) to guide decisions regarding the amount of genomic sequencing necessary to develop high-quality diagnostic DNA and protein signatures. SAP uses simulations to estimate the number of target genomes and close phylogenetic relatives (near neighbors or NNs) to sequence. We use SAP to assess whether draft data are sufficient or finished sequencing is required using Marburg and variola virus sequences. Simulations indicate that intermediate to high-quality draft with error rates of 10−3–10−5 (∼8× coverage) of target organisms is suitable for DNA signature prediction. Low-quality draft with error rates of ∼1% (3× to 6× coverage) of target isolates is inadequate for DNA signature prediction, although low-quality draft of NNs is sufficient, as long as the target genomes are of high quality. For protein signature prediction, sequencing errors in target genomes substantially reduce the detection of amino acid sequence conservation, even if the draft is of high quality. In summary, high-quality draft of target and low-quality draft of NNs appears to be a cost-effective investment for DNA signature prediction, but may lead to underestimation of predicted protein signatures.


Genome Announcements | 2017

Draft Genome Sequences from a Novel Clade of Bacillus cereus Sensu Lato Strains, Isolated from the International Space Station

Kasthuri Venkateswaran; Aleksandra Checinska Sielaff; Shashikala Ratnayake; Robert K. Pope; Thomas E. Blank; Victor G. Stepanov; George E. Fox; Sandra P. van Tongeren; Clinton Torres; Jonathan E. Allen; Crystal Jaing; Duane L. Pierson; Jay L. Perry; Sergey Koren; Adam M. Phillippy; Joy Klubnik; Todd J. Treangen; M. J. Rosovitz; Nicholas H. Bergman

ABSTRACT The draft genome sequences of six Bacillus strains, isolated from the International Space Station and belonging to the Bacillus anthracis-B. cereus-B. thuringiensis group, are presented here. These strains were isolated from the Japanese Experiment Module (one strain), U.S. Harmony Node 2 (three strains), and Russian Segment Zvezda Module (two strains).


Microbial Forensics (Second Edition) | 2011

Design of Genomic Signatures for Pathogen Identification and Characterization

Tom Slezak; Shea N. Gardner; Jonathan E. Allen; Marisa W Torres; Clinton Torres; Crystal Jaing

Publisher Summary This chapter addresses issues associated with the identification of signatures based on genomic DNA/RNA, which can be used to identify and characterize pathogens for biodefense and microbial forensic goals. Genomic signature-based identification techniques have the advantage of being precise, highly sensitive, and relatively fast in comparison to biochemical typing methods and protein signatures. Classic biochemical typing methods were developed long before knowledge of DNA and resulted in dozens of tests that are used to roughly characterize the major known pathogens. Genomic signatures can be intended for many different purposes and applied at multiple different resolutions. Organism signatures are intended to uniquely identify the organisms involved. Mechanism signatures can be best thought of as identifying particular genes that result in functional properties such as virulence, antibiotic resistance, or host range. The primary reason to identify mechanisms, independent of organisms, is to detect potential genetic engineering. A secondary reason is that nature has shared many important mechanisms on its own over the millennia, and thus they may not be sufficiently unique to identify specific organisms. Method signatures present yet another dimension of analyzing pathogens: evidence of potential bacterial genetic engineering may be seen in a genome by checking for traces of the bacterial vectors that may have been used to insert one or more foreign genes and related components into the genome being modified.


Briefings in Bioinformatics | 2003

Comparative genomics tools applied to bioterrorism defence

Tom Slezak; Thomas A. Kuczmarski; Linda M. Ott; Clinton Torres; Dan Medeiros; Jason Smith; Brian Truitt; Nisha Mulakken; Marisa Lam; Adam Zemla; Carol L. Ecale Zhou; Shea N. Gardner

Collaboration


Dive into the Clinton Torres's collaboration.

Top Co-Authors

Avatar

Shea N. Gardner

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Tom Slezak

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Adam Zemla

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Jonathan E. Allen

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Marisa W Torres

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Marisa W. Lam

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Brian R. Baker

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Carol L. Ecale Zhou

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Crystal Jaing

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Haiyin Chen-Harris

Lawrence Livermore National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge